Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Neoadjuvant Strategy in ER+/HER2- Breast Cancer (PLATO)
NCT03900637Phase 2Active, not recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2019
- Primary completion
- Oct 2023
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole, leuprolide in breast cancer, sponsored by Seoul National University Hospital. Started Nov 2019; status: active, not recruiting.
02
Drugs
letrozoleleuprolide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03900637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03900637.